Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Service & Software > Global Recombinant Antibody Expression Service Market Insights, Forecast to 2030

Global Recombinant Antibody Expression Service Market Insights, Forecast to 2030

Industry: Service & Software

Published: 2024-04-14

Pages: 125 Pages

Report ld: 2971052

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

Market Analysis and Insights: Global Recombinant Antibody Expression Service Market
The global Recombinant Antibody Expression Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Recombinant Antibody Expression Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Recombinant Antibody Expression Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Recombinant Antibody Expression Service is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Recombinant Antibody Expression Service include GenScript Biotech Corporation, Creative Biolabs, Abnova Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Covance Inc., Sino Biological Inc., ProMab Biotechnologies Inc. and LakePharma Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Recombinant Antibody Expression Service is widely used in various fields, such as Research and Development, Diagnostics, Therapeutics and Agriculture and Food, etc. Research and Development provides greatest supports to the Recombinant Antibody Expression Service industry development. In 2023, global % revenue of Recombinant Antibody Expression Service went into Research and Development filed and the proportion will reach to % in 2030.
Report Covers:
This report presents an overview of global market for Recombinant Antibody Expression Service market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Antibody Expression Service, also provides the revenue of main regions and countries. of the upcoming market potential for Recombinant Antibody Expression Service, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Recombinant Antibody Expression Service revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Antibody Expression Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Antibody Expression Service revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Report Metric
Details
Report Title
Global Recombinant Antibody Expression Service Market Insights, Forecast to 2030
Market Size Available for Years
2024-2030
Global Recombinant Antibody Expression Service Companies Covered
GenScript Biotech Corporation
Creative Biolabs
Abnova Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Covance Inc.
Sino Biological Inc.
ProMab Biotechnologies Inc.
LakePharma Inc.
Genetically Modified Animals Inc.
Atlas Antibodies AB
Absolute Antibody Ltd.
ProteoGenix
BOC Sciences
Rockland Immunochemicals Inc.
Molecular Innovations Inc.
Proteintech Group Inc.
RayBiotech Inc.
BioLegend Inc.
Genscript USA Inc.
Agilent Technologies
Novus Biologicals LLC
OriGene Technologies Inc.
ACROBiosystems
Fitzgerald Industries International
Global Recombinant Antibody Expression Service Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Antibody Expression Service Market, Segment by Type
Mammalian Cell Expression
Bacterial Expression
Yeast Expression
Insect Cell Expression
Cell-Free Expression
Transgenic Animal Expression
Plant Expression
Global Recombinant Antibody Expression Service Market, Segment by Application
Research and Development
Diagnostics
Therapeutics
Agriculture and Food
Others
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Recombinant Antibody Expression Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Recombinant Antibody Expression Service companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Antibody Expression Service revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Antibody Expression Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Mammalian Cell Expression
        1.2.3 Bacterial Expression
        1.2.4 Yeast Expression
        1.2.5 Insect Cell Expression
        1.2.6 Cell-Free Expression
        1.2.7 Transgenic Animal Expression
        1.2.8 Plant Expression
    1.3 Market by Application
        1.3.1 Global Recombinant Antibody Expression Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Research and Development
        1.3.3 Diagnostics
        1.3.4 Therapeutics
        1.3.5 Agriculture and Food
        1.3.6 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Recombinant Antibody Expression Service Market Perspective (2019-2030)
    2.2 Global Recombinant Antibody Expression Service Growth Trends by Region
        2.2.1 Recombinant Antibody Expression Service Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Recombinant Antibody Expression Service Historic Market Size by Region (2019-2024)
        2.2.3 Recombinant Antibody Expression Service Forecasted Market Size by Region (2025-2030)
    2.3 Recombinant Antibody Expression Service Market Dynamics
        2.3.1 Recombinant Antibody Expression Service Industry Trends
        2.3.2 Recombinant Antibody Expression Service Market Drivers
        2.3.3 Recombinant Antibody Expression Service Market Challenges
        2.3.4 Recombinant Antibody Expression Service Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Recombinant Antibody Expression Service by Players
        3.1.1 Global Recombinant Antibody Expression Service Revenue by Players (2019-2024)
        3.1.2 Global Recombinant Antibody Expression Service Revenue Market Share by Players (2019-2024)
    3.2 Global Recombinant Antibody Expression Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Recombinant Antibody Expression Service, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Recombinant Antibody Expression Service Market Concentration Ratio
        3.4.1 Global Recombinant Antibody Expression Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Expression Service Revenue in 2023
    3.5 Global Key Players of Recombinant Antibody Expression Service Head office and Area Served
    3.6 Global Key Players of Recombinant Antibody Expression Service, Product and Application
    3.7 Global Key Players of Recombinant Antibody Expression Service, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Antibody Expression Service Breakdown Data by Type
    4.1 Global Recombinant Antibody Expression Service Historic Market Size by Type (2019-2024)
    4.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2025-2030)

5 Recombinant Antibody Expression Service Breakdown Data by Application
    5.1 Global Recombinant Antibody Expression Service Historic Market Size by Application (2019-2024)
    5.2 Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Recombinant Antibody Expression Service Market Size (2019-2030)
    6.2 North America Recombinant Antibody Expression Service Market Size by Type
        6.2.1 North America Recombinant Antibody Expression Service Market Size by Type (2019-2024)
        6.2.2 North America Recombinant Antibody Expression Service Market Size by Type (2025-2030)
        6.2.3 North America Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    6.3 North America Recombinant Antibody Expression Service Market Size by Application
        6.3.1 North America Recombinant Antibody Expression Service Market Size by Application (2019-2024)
        6.3.2 North America Recombinant Antibody Expression Service Market Size by Application (2025-2030)
        6.3.3 North America Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    6.4 North America Recombinant Antibody Expression Service Market Size by Country
        6.4.1 North America Recombinant Antibody Expression Service Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Recombinant Antibody Expression Service Market Size by Country (2019-2024)
        6.4.3 North America Recombinant Antibody Expression Service Market Size by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

7 Europe
    7.1 Europe Recombinant Antibody Expression Service Market Size (2019-2030)
    7.2 Europe Recombinant Antibody Expression Service Market Size by Type
        7.2.1 Europe Recombinant Antibody Expression Service Market Size by Type (2019-2024)
        7.2.2 Europe Recombinant Antibody Expression Service Market Size by Type (2025-2030)
        7.2.3 Europe Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    7.3 Europe Recombinant Antibody Expression Service Market Size by Application
        7.3.1 Europe Recombinant Antibody Expression Service Market Size by Application (2019-2024)
        7.3.2 Europe Recombinant Antibody Expression Service Market Size by Application (2025-2030)
        7.3.3 Europe Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    7.4 Europe Recombinant Antibody Expression Service Market Size by Country
        7.4.1 Europe Recombinant Antibody Expression Service Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Recombinant Antibody Expression Service Market Size by Country (2019-2024)
        7.4.3 Europe Recombinant Antibody Expression Service Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Recombinant Antibody Expression Service Market Size (2019-2030)
    8.2 China Recombinant Antibody Expression Service Market Size by Type
        8.2.1 China Recombinant Antibody Expression Service Market Size by Type (2019-2024)
        8.2.2 China Recombinant Antibody Expression Service Market Size by Type (2025-2030)
        8.2.3 China Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    8.3 China Recombinant Antibody Expression Service Market Size by Application
        8.3.1 China Recombinant Antibody Expression Service Market Size by Application (2019-2024)
        8.3.2 China Recombinant Antibody Expression Service Market Size by Application (2025-2030)
        8.3.3 China Recombinant Antibody Expression Service Market Share by Application (2019-2030)

9 Asia (excluding China)
    9.1 Asia Recombinant Antibody Expression Service Market Size (2019-2030)
    9.2 Asia Recombinant Antibody Expression Service Market Size by Type
        9.2.1 Asia Recombinant Antibody Expression Service Market Size by Type (2019-2024)
        9.2.2 Asia Recombinant Antibody Expression Service Market Size by Type (2025-2030)
        9.2.3 Asia Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    9.3 Asia Recombinant Antibody Expression Service Market Size by Application
        9.3.1 Asia Recombinant Antibody Expression Service Market Size by Application (2019-2024)
        9.3.2 Asia Recombinant Antibody Expression Service Market Size by Application (2025-2030)
        9.3.3 Asia Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    9.4 Asia Recombinant Antibody Expression Service Market Size by Region
        9.4.1 Asia Recombinant Antibody Expression Service Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Recombinant Antibody Expression Service Market Size by Region (2019-2024)
        9.4.3 Asia Recombinant Antibody Expression Service Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
11.1 GenScript Biotech Corporation
11.1.1 GenScript Biotech Corporation Company Details
11.1.2 GenScript Biotech Corporation Business Overview
11.1.3 GenScript Biotech Corporation Recombinant Antibody Expression Service Introduction
11.1.4 GenScript Biotech Corporation Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.1.5 GenScript Biotech Corporation Recent Developments
11.2 Creative Biolabs
11.2.1 Creative Biolabs Company Details
11.2.2 Creative Biolabs Business Overview
11.2.3 Creative Biolabs Recombinant Antibody Expression Service Introduction
11.2.4 Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.2.5 Creative Biolabs Recent Developments
11.3 Abnova Corporation
11.3.1 Abnova Corporation Company Details
11.3.2 Abnova Corporation Business Overview
11.3.3 Abnova Corporation Recombinant Antibody Expression Service Introduction
11.3.4 Abnova Corporation Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.3.5 Abnova Corporation Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Recombinant Antibody Expression Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Bio-Rad Laboratories
11.5.1 Bio-Rad Laboratories Company Details
11.5.2 Bio-Rad Laboratories Business Overview
11.5.3 Bio-Rad Laboratories Recombinant Antibody Expression Service Introduction
11.5.4 Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.5.5 Bio-Rad Laboratories Recent Developments
11.6 Covance Inc.
11.6.1 Covance Inc. Company Details
11.6.2 Covance Inc. Business Overview
11.6.3 Covance Inc. Recombinant Antibody Expression Service Introduction
11.6.4 Covance Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.6.5 Covance Inc. Recent Developments
11.7 Sino Biological Inc.
11.7.1 Sino Biological Inc. Company Details
11.7.2 Sino Biological Inc. Business Overview
11.7.3 Sino Biological Inc. Recombinant Antibody Expression Service Introduction
11.7.4 Sino Biological Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.7.5 Sino Biological Inc. Recent Developments
11.8 ProMab Biotechnologies Inc.
11.8.1 ProMab Biotechnologies Inc. Company Details
11.8.2 ProMab Biotechnologies Inc. Business Overview
11.8.3 ProMab Biotechnologies Inc. Recombinant Antibody Expression Service Introduction
11.8.4 ProMab Biotechnologies Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.8.5 ProMab Biotechnologies Inc. Recent Developments
11.9 LakePharma Inc.
11.9.1 LakePharma Inc. Company Details
11.9.2 LakePharma Inc. Business Overview
11.9.3 LakePharma Inc. Recombinant Antibody Expression Service Introduction
11.9.4 LakePharma Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.9.5 LakePharma Inc. Recent Developments
11.10 Genetically Modified Animals Inc.
11.10.1 Genetically Modified Animals Inc. Company Details
11.10.2 Genetically Modified Animals Inc. Business Overview
11.10.3 Genetically Modified Animals Inc. Recombinant Antibody Expression Service Introduction
11.10.4 Genetically Modified Animals Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.10.5 Genetically Modified Animals Inc. Recent Developments
11.11 Atlas Antibodies AB
11.11.1 Atlas Antibodies AB Company Details
11.11.2 Atlas Antibodies AB Business Overview
11.11.3 Atlas Antibodies AB Recombinant Antibody Expression Service Introduction
11.11.4 Atlas Antibodies AB Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.11.5 Atlas Antibodies AB Recent Developments
11.12 Absolute Antibody Ltd.
11.12.1 Absolute Antibody Ltd. Company Details
11.12.2 Absolute Antibody Ltd. Business Overview
11.12.3 Absolute Antibody Ltd. Recombinant Antibody Expression Service Introduction
11.12.4 Absolute Antibody Ltd. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.12.5 Absolute Antibody Ltd. Recent Developments
11.13 ProteoGenix
11.13.1 ProteoGenix Company Details
11.13.2 ProteoGenix Business Overview
11.13.3 ProteoGenix Recombinant Antibody Expression Service Introduction
11.13.4 ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.13.5 ProteoGenix Recent Developments
11.14 BOC Sciences
11.14.1 BOC Sciences Company Details
11.14.2 BOC Sciences Business Overview
11.14.3 BOC Sciences Recombinant Antibody Expression Service Introduction
11.14.4 BOC Sciences Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.14.5 BOC Sciences Recent Developments
11.15 Rockland Immunochemicals Inc.
11.15.1 Rockland Immunochemicals Inc. Company Details
11.15.2 Rockland Immunochemicals Inc. Business Overview
11.15.3 Rockland Immunochemicals Inc. Recombinant Antibody Expression Service Introduction
11.15.4 Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.15.5 Rockland Immunochemicals Inc. Recent Developments
11.16 Molecular Innovations Inc.
11.16.1 Molecular Innovations Inc. Company Details
11.16.2 Molecular Innovations Inc. Business Overview
11.16.3 Molecular Innovations Inc. Recombinant Antibody Expression Service Introduction
11.16.4 Molecular Innovations Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.16.5 Molecular Innovations Inc. Recent Developments
11.17 Proteintech Group Inc.
11.17.1 Proteintech Group Inc. Company Details
11.17.2 Proteintech Group Inc. Business Overview
11.17.3 Proteintech Group Inc. Recombinant Antibody Expression Service Introduction
11.17.4 Proteintech Group Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.17.5 Proteintech Group Inc. Recent Developments
11.18 RayBiotech Inc.
11.18.1 RayBiotech Inc. Company Details
11.18.2 RayBiotech Inc. Business Overview
11.18.3 RayBiotech Inc. Recombinant Antibody Expression Service Introduction
11.18.4 RayBiotech Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.18.5 RayBiotech Inc. Recent Developments
11.19 BioLegend Inc.
11.19.1 BioLegend Inc. Company Details
11.19.2 BioLegend Inc. Business Overview
11.19.3 BioLegend Inc. Recombinant Antibody Expression Service Introduction
11.19.4 BioLegend Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.19.5 BioLegend Inc. Recent Developments
11.20 Genscript USA Inc.
11.20.1 Genscript USA Inc. Company Details
11.20.2 Genscript USA Inc. Business Overview
11.20.3 Genscript USA Inc. Recombinant Antibody Expression Service Introduction
11.20.4 Genscript USA Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.20.5 Genscript USA Inc. Recent Developments
11.21 Agilent Technologies
11.21.1 Agilent Technologies Company Details
11.21.2 Agilent Technologies Business Overview
11.21.3 Agilent Technologies Recombinant Antibody Expression Service Introduction
11.21.4 Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.21.5 Agilent Technologies Recent Developments
11.22 Novus Biologicals LLC
11.22.1 Novus Biologicals LLC Company Details
11.22.2 Novus Biologicals LLC Business Overview
11.22.3 Novus Biologicals LLC Recombinant Antibody Expression Service Introduction
11.22.4 Novus Biologicals LLC Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.22.5 Novus Biologicals LLC Recent Developments
11.23 OriGene Technologies Inc.
11.23.1 OriGene Technologies Inc. Company Details
11.23.2 OriGene Technologies Inc. Business Overview
11.23.3 OriGene Technologies Inc. Recombinant Antibody Expression Service Introduction
11.23.4 OriGene Technologies Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.23.5 OriGene Technologies Inc. Recent Developments
11.24 ACROBiosystems
11.24.1 ACROBiosystems Company Details
11.24.2 ACROBiosystems Business Overview
11.24.3 ACROBiosystems Recombinant Antibody Expression Service Introduction
11.24.4 ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.24.5 ACROBiosystems Recent Developments
11.25 Fitzgerald Industries International
11.25.1 Fitzgerald Industries International Company Details
11.25.2 Fitzgerald Industries International Business Overview
11.25.3 Fitzgerald Industries International Recombinant Antibody Expression Service Introduction
11.25.4 Fitzgerald Industries International Revenue in Recombinant Antibody Expression Service Business (2019-2024)
11.25.5 Fitzgerald Industries International Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Recombinant Antibody Expression Service Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Mammalian Cell Expression
    Table 3. Key Players of Bacterial Expression
    Table 4. Key Players of Yeast Expression
    Table 5. Key Players of Insect Cell Expression
    Table 6. Key Players of Cell-Free Expression
    Table 7. Key Players of Transgenic Animal Expression
    Table 8. Key Players of Plant Expression
    Table 9. Global Recombinant Antibody Expression Service Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 10. Global Recombinant Antibody Expression Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 11. Global Recombinant Antibody Expression Service Market Size by Region (2019-2024) & (US$ Million)
    Table 12. Global Recombinant Antibody Expression Service Market Share by Region (2019-2024)
    Table 13. Global Recombinant Antibody Expression Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 14. Global Recombinant Antibody Expression Service Market Share by Region (2025-2030)
    Table 15. Recombinant Antibody Expression Service Market Trends
    Table 16. Recombinant Antibody Expression Service Market Drivers
    Table 17. Recombinant Antibody Expression Service Market Challenges
    Table 18. Recombinant Antibody Expression Service Market Restraints
    Table 19. Global Recombinant Antibody Expression Service Revenue by Players (2019-2024) & (US$ Million)
    Table 20. Global Recombinant Antibody Expression Service Revenue Share by Players (2019-2024)
    Table 21. Global Top Recombinant Antibody Expression Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Expression Service as of 2023)
    Table 22. Global Recombinant Antibody Expression Service Industry Ranking 2022 VS 2023 VS 2024
    Table 23. Global 5 Largest Players Market Share by Recombinant Antibody Expression Service Revenue (CR5 and HHI) & (2019-2024)
    Table 24. Global Key Players of Recombinant Antibody Expression Service, Headquarters and Area Served
    Table 25. Global Key Players of Recombinant Antibody Expression Service, Product and Application
    Table 26. Global Key Players of Recombinant Antibody Expression Service, Product and Application
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 29. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2019-2024)
    Table 30. Global Recombinant Antibody Expression Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 31. Global Recombinant Antibody Expression Service Revenue Market Share by Type (2025-2030)
    Table 32. Global Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 33. Global Recombinant Antibody Expression Service Revenue Share by Application (2019-2024)
    Table 34. Global Recombinant Antibody Expression Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 35. Global Recombinant Antibody Expression Service Revenue Share by Application (2025-2030)
    Table 36. North America Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 37. North America Recombinant Antibody Expression Service Market Size by Type (2025-2030) & (US$ Million)
    Table 38. North America Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 39. North America Recombinant Antibody Expression Service Market Size by Application (2025-2030) & (US$ Million)
    Table 40. North America Recombinant Antibody Expression Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. North America Recombinant Antibody Expression Service Market Size by Country (2019-2024) & (US$ Million)
    Table 42. North America Recombinant Antibody Expression Service Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Europe Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 44. Europe Recombinant Antibody Expression Service Market Size by Type (2025-2030) & (US$ Million)
    Table 45. Europe Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 46. Europe Recombinant Antibody Expression Service Market Size by Application (2025-2030) & (US$ Million)
    Table 47. Europe Recombinant Antibody Expression Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 48. Europe Recombinant Antibody Expression Service Market Size by Country (2019-2024) & (US$ Million)
    Table 49. Europe Recombinant Antibody Expression Service Market Size by Country (2025-2030) & (US$ Million)
    Table 50. China Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 51. China Recombinant Antibody Expression Service Market Size by Type (2025-2030) & (US$ Million)
    Table 52. China Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 53. China Recombinant Antibody Expression Service Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 55. Asia Recombinant Antibody Expression Service Market Size by Type (2025-2030) & (US$ Million)
    Table 56. Asia Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 57. Asia Recombinant Antibody Expression Service Market Size by Application (2025-2030) & (US$ Million)
    Table 58. Asia Recombinant Antibody Expression Service Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 59. Asia Recombinant Antibody Expression Service Market Size by Region (2019-2024) & (US$ Million)
    Table 60. Asia Recombinant Antibody Expression Service Market Size by Region (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Type (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Type (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Application (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Application (2025-2030) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 66. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country (2019-2024) & (US$ Million)
    Table 67. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size by Country (2025-2030) & (US$ Million)
    Table 68. GenScript Biotech Corporation Company Details
    Table 69. GenScript Biotech Corporation Business Overview
    Table 70. GenScript Biotech Corporation Recombinant Antibody Expression Service Product
    Table 71. GenScript Biotech Corporation Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 72. GenScript Biotech Corporation Recent Developments
    Table 73. Creative Biolabs Company Details
    Table 74. Creative Biolabs Business Overview
    Table 75. Creative Biolabs Recombinant Antibody Expression Service Product
    Table 76. Creative Biolabs Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 77. Creative Biolabs Recent Developments
    Table 78. Abnova Corporation Company Details
    Table 79. Abnova Corporation Business Overview
    Table 80. Abnova Corporation Recombinant Antibody Expression Service Product
    Table 81. Abnova Corporation Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 82. Abnova Corporation Recent Developments
    Table 83. Thermo Fisher Scientific Company Details
    Table 84. Thermo Fisher Scientific Business Overview
    Table 85. Thermo Fisher Scientific Recombinant Antibody Expression Service Product
    Table 86. Thermo Fisher Scientific Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 87. Thermo Fisher Scientific Recent Developments
    Table 88. Bio-Rad Laboratories Company Details
    Table 89. Bio-Rad Laboratories Business Overview
    Table 90. Bio-Rad Laboratories Recombinant Antibody Expression Service Product
    Table 91. Bio-Rad Laboratories Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 92. Bio-Rad Laboratories Recent Developments
    Table 93. Covance Inc. Company Details
    Table 94. Covance Inc. Business Overview
    Table 95. Covance Inc. Recombinant Antibody Expression Service Product
    Table 96. Covance Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 97. Covance Inc. Recent Developments
    Table 98. Sino Biological Inc. Company Details
    Table 99. Sino Biological Inc. Business Overview
    Table 100. Sino Biological Inc. Recombinant Antibody Expression Service Product
    Table 101. Sino Biological Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 102. Sino Biological Inc. Recent Developments
    Table 103. ProMab Biotechnologies Inc. Company Details
    Table 104. ProMab Biotechnologies Inc. Business Overview
    Table 105. ProMab Biotechnologies Inc. Recombinant Antibody Expression Service Product
    Table 106. ProMab Biotechnologies Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 107. ProMab Biotechnologies Inc. Recent Developments
    Table 108. LakePharma Inc. Company Details
    Table 109. LakePharma Inc. Business Overview
    Table 110. LakePharma Inc. Recombinant Antibody Expression Service Product
    Table 111. LakePharma Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 112. LakePharma Inc. Recent Developments
    Table 113. Genetically Modified Animals Inc. Company Details
    Table 114. Genetically Modified Animals Inc. Business Overview
    Table 115. Genetically Modified Animals Inc. Recombinant Antibody Expression Service Product
    Table 116. Genetically Modified Animals Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 117. Genetically Modified Animals Inc. Recent Developments
    Table 118. Atlas Antibodies AB Company Details
    Table 119. Atlas Antibodies AB Business Overview
    Table 120. Atlas Antibodies AB Recombinant Antibody Expression Service Product
    Table 121. Atlas Antibodies AB Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 122. Atlas Antibodies AB Recent Developments
    Table 123. Absolute Antibody Ltd. Company Details
    Table 124. Absolute Antibody Ltd. Business Overview
    Table 125. Absolute Antibody Ltd. Recombinant Antibody Expression Service Product
    Table 126. Absolute Antibody Ltd. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 127. Absolute Antibody Ltd. Recent Developments
    Table 128. ProteoGenix Company Details
    Table 129. ProteoGenix Business Overview
    Table 130. ProteoGenix Recombinant Antibody Expression Service Product
    Table 131. ProteoGenix Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 132. ProteoGenix Recent Developments
    Table 133. BOC Sciences Company Details
    Table 134. BOC Sciences Business Overview
    Table 135. BOC Sciences Recombinant Antibody Expression Service Product
    Table 136. BOC Sciences Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 137. BOC Sciences Recent Developments
    Table 138. Rockland Immunochemicals Inc. Company Details
    Table 139. Rockland Immunochemicals Inc. Business Overview
    Table 140. Rockland Immunochemicals Inc. Recombinant Antibody Expression Service Product
    Table 141. Rockland Immunochemicals Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 142. Rockland Immunochemicals Inc. Recent Developments
    Table 143. Molecular Innovations Inc. Company Details
    Table 144. Molecular Innovations Inc. Business Overview
    Table 145. Molecular Innovations Inc. Recombinant Antibody Expression Service Product
    Table 146. Molecular Innovations Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 147. Molecular Innovations Inc. Recent Developments
    Table 148. Proteintech Group Inc. Company Details
    Table 149. Proteintech Group Inc. Business Overview
    Table 150. Proteintech Group Inc. Recombinant Antibody Expression Service Product
    Table 151. Proteintech Group Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 152. Proteintech Group Inc. Recent Developments
    Table 153. RayBiotech Inc. Company Details
    Table 154. RayBiotech Inc. Business Overview
    Table 155. RayBiotech Inc. Recombinant Antibody Expression Service Product
    Table 156. RayBiotech Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 157. RayBiotech Inc. Recent Developments
    Table 158. BioLegend Inc. Company Details
    Table 159. BioLegend Inc. Business Overview
    Table 160. BioLegend Inc. Recombinant Antibody Expression Service Product
    Table 161. BioLegend Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 162. BioLegend Inc. Recent Developments
    Table 163. Genscript USA Inc. Company Details
    Table 164. Genscript USA Inc. Business Overview
    Table 165. Genscript USA Inc. Recombinant Antibody Expression Service Product
    Table 166. Genscript USA Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 167. Genscript USA Inc. Recent Developments
    Table 168. Agilent Technologies Company Details
    Table 169. Agilent Technologies Business Overview
    Table 170. Agilent Technologies Recombinant Antibody Expression Service Product
    Table 171. Agilent Technologies Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 172. Agilent Technologies Recent Developments
    Table 173. Novus Biologicals LLC Company Details
    Table 174. Novus Biologicals LLC Business Overview
    Table 175. Novus Biologicals LLC Recombinant Antibody Expression Service Product
    Table 176. Novus Biologicals LLC Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 177. Novus Biologicals LLC Recent Developments
    Table 178. OriGene Technologies Inc. Company Details
    Table 179. OriGene Technologies Inc. Business Overview
    Table 180. OriGene Technologies Inc. Recombinant Antibody Expression Service Product
    Table 181. OriGene Technologies Inc. Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 182. OriGene Technologies Inc. Recent Developments
    Table 183. ACROBiosystems Company Details
    Table 184. ACROBiosystems Business Overview
    Table 185. ACROBiosystems Recombinant Antibody Expression Service Product
    Table 186. ACROBiosystems Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 187. ACROBiosystems Recent Developments
    Table 188. Fitzgerald Industries International Company Details
    Table 189. Fitzgerald Industries International Business Overview
    Table 190. Fitzgerald Industries International Recombinant Antibody Expression Service Product
    Table 191. Fitzgerald Industries International Revenue in Recombinant Antibody Expression Service Business (2019-2024) & (US$ Million)
    Table 192. Fitzgerald Industries International Recent Developments
    Table 193. Research Programs/Design for This Report
    Table 194. Key Data Information from Secondary Sources
    Table 195. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Antibody Expression Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Recombinant Antibody Expression Service Market Share by Type: 2023 VS 2030
    Figure 3. Mammalian Cell Expression Features
    Figure 4. Bacterial Expression Features
    Figure 5. Yeast Expression Features
    Figure 6. Insect Cell Expression Features
    Figure 7. Cell-Free Expression Features
    Figure 8. Transgenic Animal Expression Features
    Figure 9. Plant Expression Features
    Figure 10. Global Recombinant Antibody Expression Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 11. Global Recombinant Antibody Expression Service Market Share by Application: 2023 VS 2030
    Figure 12. Research and Development Case Studies
    Figure 13. Diagnostics Case Studies
    Figure 14. Therapeutics Case Studies
    Figure 15. Agriculture and Food Case Studies
    Figure 16. Others Case Studies
    Figure 17. Recombinant Antibody Expression Service Report Years Considered
    Figure 18. Global Recombinant Antibody Expression Service Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 19. Global Recombinant Antibody Expression Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 20. Global Recombinant Antibody Expression Service Market Share by Region: 2023 VS 2030
    Figure 21. Global Recombinant Antibody Expression Service Market Share by Players in 2023
    Figure 22. Global Top Recombinant Antibody Expression Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody Expression Service as of 2023)
    Figure 23. The Top 10 and 5 Players Market Share by Recombinant Antibody Expression Service Revenue in 2023
    Figure 24. North America Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. North America Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    Figure 26. North America Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    Figure 27. North America Recombinant Antibody Expression Service Market Share by Country (2019-2030)
    Figure 28. United States Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Canada Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Europe Recombinant Antibody Expression Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 31. Europe Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    Figure 32. Europe Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    Figure 33. Europe Recombinant Antibody Expression Service Market Share by Country (2019-2030)
    Figure 34. Germany Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. France Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. U.K. Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Italy Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Russia Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Nordic Countries Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. China Recombinant Antibody Expression Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. China Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    Figure 42. China Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    Figure 43. Asia Recombinant Antibody Expression Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 44. Asia Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    Figure 45. Asia Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    Figure 46. Asia Recombinant Antibody Expression Service Market Share by Region (2019-2030)
    Figure 47. Japan Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. South Korea Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. China Taiwan Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Southeast Asia Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. India Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Australia Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 54. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Share by Type (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Share by Application (2019-2030)
    Figure 56. Middle East, Africa, and Latin America Recombinant Antibody Expression Service Market Share by Country (2019-2030)
    Figure 57. Brazil Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Mexico Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Turkey Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Saudi Arabia Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. Israel Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. GCC Countries Recombinant Antibody Expression Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 63. GenScript Biotech Corporation Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 64. Creative Biolabs Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 65. Abnova Corporation Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 66. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 67. Bio-Rad Laboratories Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 68. Covance Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 69. Sino Biological Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 70. ProMab Biotechnologies Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 71. LakePharma Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 72. Genetically Modified Animals Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 73. Atlas Antibodies AB Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 74. Absolute Antibody Ltd. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 75. ProteoGenix Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 76. BOC Sciences Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 77. Rockland Immunochemicals Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 78. Molecular Innovations Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 79. Proteintech Group Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 80. RayBiotech Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 81. BioLegend Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 82. Genscript USA Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 83. Agilent Technologies Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 84. Novus Biologicals LLC Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 85. OriGene Technologies Inc. Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 86. ACROBiosystems Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 87. Fitzgerald Industries International Revenue Growth Rate in Recombinant Antibody Expression Service Business (2019-2024)
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed

Description

Market Analysis and Insights: Global Recombinant Antibody Expression Service Market
The global Recombinant Antibody Expression Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Market Segmentation

Related Reports

Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-13
Pages: 158
USD 3950.00
(Single User License)
Global Recombinant Antibody Expression Service Market Research Report 2025
The global market for Recombinant Antibody Expression Service was valued at US$ 4456 million in the year 2024 and is projected to reach a revised size of US$ 7254 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-09-20
Pages: 119
USD 2900.00
(Single User License)
Recombinant Antibody Expression Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 156
USD 3950.00
(Single User License)
Global Recombinant Antibody Expression Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Antibody Expression Service market size was US$ 4456 million in 2024 and is forecast to a readjusted size of US$ 7254 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-09-20
Pages: 122
USD 4250.00
(Single User License)
Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ 4456 million in 2024 and is forecast to a readjusted size of US$ 7254 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-09-20
Pages: 166
USD 3950.00
(Single User License)
Global Recombinant Antibody Expression Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Antibody Expression Service market is projected to grow from US$ 4456 million in 2024 to US$ 7254 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 183
USD 4900.00
(Single User License)
Global Recombinant Antibody Expression Service Market Research Report 2026
The global Recombinant Antibody Expression Service market was valued at US$ 4780 million in 2025 and is anticipated to reach US$ 7724 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 161
USD 2900.00
(Single User License)
Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ 4780 million in 2025 and is projected to reach US$ 7724 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 170
USD 3950.00
(Single User License)

Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-13
Pages: 158
USD 3950.00 ()
Global Recombinant Antibody Expression Service Market Research Report 2025
The global market for Recombinant Antibody Expression Service was valued at US$ 4456 million in the year 2024 and is projected to reach a revised size of US$ 7254 million by 2031, growing at a CAGR of 7.2% during the forecast period.
Published: 2025-09-20
Pages: 119
USD 2900.00 ()
Recombinant Antibody Expression Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-03
Pages: 156
USD 3950.00 ()
Global Recombinant Antibody Expression Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Antibody Expression Service market size was US$ 4456 million in 2024 and is forecast to a readjusted size of US$ 7254 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-09-20
Pages: 122
USD 4250.00 ()
Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ 4456 million in 2024 and is forecast to a readjusted size of US$ 7254 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Published: 2025-09-20
Pages: 166
USD 3950.00 ()
Global Recombinant Antibody Expression Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Antibody Expression Service market is projected to grow from US$ 4456 million in 2024 to US$ 7254 million by 2031, at a CAGR of 7.2% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-03
Pages: 183
USD 4900.00 ()
Global Recombinant Antibody Expression Service Market Research Report 2026
The global Recombinant Antibody Expression Service market was valued at US$ 4780 million in 2025 and is anticipated to reach US$ 7724 million by 2032, at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 161
USD 2900.00 ()
Recombinant Antibody Expression Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Antibody Expression Service was estimated to be worth US$ 4780 million in 2025 and is projected to reach US$ 7724 million, growing at a CAGR of 7.2% from 2026 to 2032.
Published: 2026-02-11
Pages: 170
USD 3950.00 ()